Will Baillie Gifford’s big bet on Moderna pay off?
Omicron variant has helped the stock recoup heavy losses but analysts question whether it can sustain sales momentum
- News
-
- Analysis
-
- Investments
-
-
-
Top story
-
-
-
- Video
-
Equities
-
-
Strategic Equity Capital duo: Overexuberance in UK equity market calls for investor discipline
Adam Khanbhai and Ken Wotton say domestic equity market prospects have improved but significant challenges remain
-
Baillie Gifford seeks to double unlisted exposure in yet another strategy
Baillie Gifford European Growth trust had no unquoted exposure when it was swiped from Edinburgh Partners
-
Keith Ashworth-Lord ascribes market-cap drift to successful stock picks
SDL manager responds to Interactive Investor placing Buffettology fund under review
-
Speedbumps expected on equity road to recovery
‘With the arrival of autumn, clouds started to gather on the horizon’
-
Martin Currie adds India specialist from Jupiter to £5bn team
Aimee Truesdale had been an assistant fund manager at Jupiter
-
Ashish Swarup: Why strategy trumps AUM growth for our fund
Video: Former First State manager on setting up his own boutique and how capacity constraint is vital for his EM fund
-
M&G adds to private assets with £19m investment in self-driving tech start-up
Follows fund group’s investment in Oxford Nanopore pre-IPO and pair of early-stage carbon capture and storage companies
-
II places Lindsell Train Japan fund under review for performance issues
Michael Lindsell’s fund has lost investors 9% in one year while the Topix has risen 25%
-
Majedie slams deal to take Daily Mail owner private as ‘substantially below’ fair value
Manager Chris Field says DMGT is worth double what the Rothmere family are willing to pay
-
Colin Morton’s UK equities team transfers to Martin Currie
Morton will continue to lead Franklin Templeton UK equities team
